Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November

WATERTOWN, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Foghorn(®) Therapeutics Inc. (Nasdaq: FHTX), a biotechnology company pioneering a new class of medicines against challenging targets in oncology and immunology & inflammation, today announced that management will participate in the Guggenheim Third Annual Healthcare Innovation Conference, Stifel 2026 Healthcare Conference, and Jefferies 2026 London Healthcare Conference.

Guggenheim Third Annual Healthcare Innovation Conference * Fireside Chat: Tuesday, November 10, 2026, at 3:30 p.m. ET * Presenter: Adrian Gottschalk, President and Chief Executive Officer * Registration link: Register here * Management will also participate in one-on-one meetings Stifel 2026 Healthcare Conference * Presentation: Wednesday, November 11, 2026, at 10:00 a.m. ET * Presenter: Adrian Gottschalk, President and Chief Executive Officer * Management will also participate in one-on-one meetings Jefferies 2026 London Healthcare Conference * Fireside Chat: Monday, November 16, 2026, at 4:30 p.m. GMT * Presenter: Adrian Gottschalk, President and Chief Executive Officer * Management will also participate in one-on-one meetings A webcast of the Guggenheim fireside chat can be accessed under “Events & Presentations” in the Investors section of the Company’s website here and will be available for 90 days.